Literature DB >> 8255618

Inguinal hernia and umbilical anomalies.

L R Scherer1, J L Grosfeld.   

Abstract

Inguinal hernias and umbilical anomalies remain the most common congenital anomalies. The loss of testis, ovary, or a portion of bowel from an irreducible hernia and the infectious complications of umbilical anomalies continue to be a threat to infants and young children. This article reviews the embryology, clinical features, and treatments of these anomalies and discusses some of the unusual and special considerations of these children.

Entities:  

Mesh:

Year:  1993        PMID: 8255618     DOI: 10.1016/s0031-3955(16)38652-7

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  6 in total

Review 1.  Irreducible indirect inguinal hernia containing uterus, ovaries, and Fallopian tubes.

Authors:  T Okada; S Sasaki; S Honda; H Miyagi; M Minato; S Todo
Journal:  Hernia       Date:  2011-01-07       Impact factor: 4.739

Review 2.  Sonography of pediatric superficial lumps and bumps: illustrative examples from head to toe.

Authors:  Anmol Gupta Bansal; Henrietta Kotlus Rosenberg
Journal:  Pediatr Radiol       Date:  2017-08-04

3.  Umbilical hernia repair in children: is pressure dressing necessary.

Authors:  Jamal M Merei
Journal:  Pediatr Surg Int       Date:  2006-04-25       Impact factor: 1.827

4.  Contralateral inguinal hernia in childhood and youth: which child will develop a contralateral inguinal hernia?

Authors:  G Steinau; G Böhm; P Vaassen; T Wenzl; V Schumpelick
Journal:  Hernia       Date:  2008-07-02       Impact factor: 4.739

5.  Contralateral exploration for unilateral inguinal hernia in females: risk factors and surgical findings.

Authors:  N Zampieri; V Zuin; A Ottolenghi; F S Camoglio
Journal:  Hernia       Date:  2008-05-22       Impact factor: 4.739

6.  A novel incision for groin pathologies in children: the low inguinal groove approach.

Authors:  I H Gökçora; A Yagmurlu
Journal:  Hernia       Date:  2003-06-11       Impact factor: 4.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.